2026 HAEi Regional Conference Americas
Oct 23 - Oct 25, 2026
- Title: Oral Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks: Regional Subgroup Analysis From the Phase 3 RAPIDe-3 Trial
Presenter: Adil Adatia, M.D.
Format: Poster Presentation + Short Talk
Date, time: Friday, October 23, 2026, 6:35 p.m. CEST (12:35 p.m. EDT) - Title: End of Progression of Hereditary Angioedema Attack Manifestations with Oral Deucrictibant Immediate-Release Capsule: Results From the RAPIDe-3 Phase 3 Trial
Presenter: Raffi Tachdjian, M.D., MPH
Format: Poster Presentation
Date, time: Friday, October 23, 2026, 6:50 p.m. CEST (12:50 p.m. EDT) - Title: CHAPTER-1 Open-Label Extension Study: Long-Term Prophylactic Treatment with Oral Deucrictibant Improved Health-Related Quality of Life in Participants with Hereditary Angioedema
Presenter: Hugo Chapdelaine, M.D.
Format: Poster Presentation
Date, time: Friday, October 23, 2026, 6:50 p.m. CEST (12:50 p.m. EDT) - Title: Qualitative Insights From RAPIDe-3: Oral Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks
Presenter: Anete S. Grumach, M.D., Ph.D.
Format: Poster Presentation
Date, time: Friday, October 23, 2026, 6:50 p.m. CEST (12:50 p.m. EDT) - Title: Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Long-Term Safety and Efficacy Results From the Phase 2 CHAPTER-1 Open-Label Extension Study
Presenter: Markus Magerl, M.D.
Format: Oral Presentation
Date, time: Saturday, October 24, 2026, 11:40 a.m. CEST (5:40 a.m. EDT)